BeStock  
Stocks › Biotechnology › RLAY

Relay Therapeutics RLAY

US equityMarket cap rank #2302Biotechnology
$16.12 +$0.21 (+1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.19 +0.46%
Open$15.59
Prev close$15.91
Day range$15.17 – $16.33
Volume3.98M
Market cap$3.56B
P/E (TTM)–
Dividend yield–

RLAY Stock News

Headlines matching Relay Therapeutics or the RLAY ticker, most recent first.

  • JonesTrading Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $20Market news · 28 Sep 2026 · Direct mention
  • CCORF Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $29Market news · 8 Aug 2026 · Direct mention
  • Barclays Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $30 PositiveMarket news · 7 Aug 2026 · Direct mention
  • TD Cowen Maintains Relay Therapeutics(RLAY.US) With Buy RatingMarket news · 7 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Relay Therapeutics(RLAY.US) With Buy RatingMarket news · 4 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $29Market news · 21 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $29 PositiveMarket news · 20 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Announces Target Price $31Market news · 14 Aug 2026 · Direct mention
  • Citizens JMP Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $26 PositiveMarket news · 10 Aug 2026 · Direct mention
  • Goldman Sachs Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $31 PositiveMarket news · 22 Jul 2026 · Direct mention
  • CCORF Initiates Relay Therapeutics(RLAY.US) With Buy Rating, Announces Target Price $29Market news · 16 Jul 2026 · Direct mention
  • Goldman Sachs Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $22Market news · 3 Jun 2026 · Direct mention
  • Analysts Are Bullish on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), Relay Therapeutics (RLAY) PositiveTipRanks · 18 Jun 2026 · Direct mention
  • Oppenheimer Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $18Market news · 6 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Relay Therapeutics(RLAY.US), With a Forecast Between $18 to $21Market news · 6 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on RLAY.

Sign in to join the discussion.

Scroll to Top